The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion

Theodoros Foukakis1, Amy Y M Au, Göran Wallin

  • 1Department of Molecular Medicine and Surgery, Karolinska University Hospital, CMM L8:01, SE-171 76 Stockholm, Sweden. theodoros.foukakis@ki.se

Abstract

Insights

NORE1A, a tumor suppressor, is suppressed in follicular thyroid cancers with PAX8-PPARgamma translocations. This Ras effector

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The Ras effector NORE1A (RASSF5A) acts as a tumor suppressor and is inactivated in various human cancers.
  • NORE1A's role in thyroid cancer has not been previously investigated.

Purpose of the Study:

  • To determine if NORE1A is implicated in the development of follicular thyroid cancer (FTC).

Main Methods:

  • Quantitative RT-PCR was used to analyze NORE1A expression in FTCs, adenomas, and normal thyroid tissues.
  • Analysis included RASSF1A expression, RAS mutations, and PAX8-PPARgamma fusions.
  • NORE1A promoter methylation was assessed using bisulfite restriction endonuclease assay.

Main Results:

  • FTCs with PAX8-PPARgamma translocations showed significantly reduced NORE1A expression.
  • RAS mutations and NORE1A down-regulation were found to be mutually exclusive.
  • A reduction in RASSF1A expression was observed, but with limited correlation to NORE1A levels.
  • No NORE1A promoter methylation was detected in any of the analyzed thyroid tumors.

Conclusions:

  • NORE1A, a Ras effector, is suppressed in FTCs that harbor PAX8-PPARgamma translocations.
  • These findings suggest a potential role for NORE1A in FTC pathogenesis, particularly in tumors with specific genetic alterations.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Directionality of Nuclear Transport01:42

Directionality of Nuclear Transport

Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of  Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...